期刊文献+

腹腔镜与开腹手术治疗浆膜浸润结直肠癌预后对比研究 被引量:8

Laparoscopic versus open surgery in treating serosa-invaded colorectal cancer:a comparative study of prognosis
原文传递
导出
摘要 目的评价腹腔镜及开腹手术治疗浆膜浸润结直肠癌病人的预后。方法回顾性分析2003年6月至2007年6月南方医科大学附属南方医院收治的浆膜浸润结直肠癌病人的临床、病理资料及随访数据。对两组病人生存及复发情况进行比较。结果腹腔镜组和开腹组病人的基线数据及随访时间差异无统计学意义。腹腔镜组总死亡率为20.7%,开腹组为28.9%,两组之间差异无统计学意义(P=0.234);腹腔镜组肿瘤相关死亡率为17.2%,开腹组为26.8%,两组之间差异无统计学意义(P=0.105);腹腔镜组复发率为12.1%,开腹组为26.8%,差异有统计学意义(P=0.024)。生存分析显示腹腔镜组病人累积无复发率高于开腹组(P=0.035),两组病人累积总存活率(P=0.159)及肿瘤相关存活率(P=0.083)差异无统计学意义。结论对于浆膜侵润的结直肠癌,腹腔镜组病人复发率明显低于开腹组,因此可以获得部分优于开腹手术的结果。 Objective To evaluate the prognosis between laparoscopic and open approach in treatment of serosa-invaded colorectal cancer. Methods The clinicopathological and follow-up data of patients with serosa-invaded colorectal cancer in the Nan fang Hospital of Southern Medical University from Jun. 2003 to Jun. 2007 were analyzed retrospectively. Recurrence and survival rates were compared respectively between two groups. Results There were no statistically significant differences of baseline data and follow up period between laparoscopic surgery (LS) and open surgery (OS) groups. No significant differences were observed in overall mortality (20.7 % in LS and 28.9 % in OS, P= 0.234) and cancer-related mortality (17.2% in LS and 26.8 % in OS, P =0.105). The difference of recurrence rate (12.1% in LS and 26.8 % in OS, P= 0.024) between the two groups was significant. As survival analysis showed, there were no significant differences in cumulative overall survival(P=0.159) and cumulative cancer-related survival(P= 0.083). The difference of recurrence-free rates between the two groups was significant(P=0.024). Conclusion The recurrence rate of LS was fewer obviously than OS, sO the laparoseopic surgery can obtain some superior outcomes compared with open surgery for serosa-invaded colorectal cancer.
出处 《中国实用外科杂志》 CSCD 北大核心 2012年第1期88-91,共4页 Chinese Journal of Practical Surgery
关键词 浆膜浸润结直肠癌 腹腔镜手术 开腹手术 预后 serosa-invaded colorectal cancer laparoscopic surgery open surgery prognosis
  • 相关文献

参考文献17

  • 1Fleshman J, Sargent DJ, Green E, et al. Laparoscopic colectomy for cancer is not inferior to open surgery based on 5-year data from the COST Study Group trial [J]. Ann Surg,2007,246(4): 655-664.
  • 2Jayne DG, Guillou PJ, Thorpe H, et al. Randomized trial of lapa- roscopic-assisted resection of colorectal carcinoma: 3-year re- sults of the UK MRC CLASICC Trial Group [J]. J Clin Oncol, 2007,25(21):3061-3068.
  • 3Liang JT, Huang KC, Lai HS, et al. Oncologic results of laparo- scopic versus conventional open surgery for stage Ⅱ or Ⅲ left-sided colon cancers: a randomized controlled trial [J]. Ann Surg 0ncol,2007,14(1):109-117.
  • 4Lacy AM, Delgado S, Castells A, et al. The long-term results of a randomized clinical trial of laparoscopy-assisted versus open surgery for colon eaneer[J]. Ann Surg,2008,248(1):l-7.
  • 5梁耀泽,余江,张策,王亚楠,程侠,黄枫,李国新.基于临床数据挖掘技术的腹腔镜结直肠癌手术评估体系的构建及应用[J].中华胃肠外科杂志,2010,13(10):741-744. 被引量:11
  • 6Edge SB, Byrd DR, Compton CC. AJCC Cancer Staging Manual [M]. 7th ed. New York:Springer,2010.
  • 7Veldkamp R, Gholghesaei M, Bonjer HJ, et al. Laparoscopic re- section of colon Cancer: consensus of the European Association of Endoscopic Surgery (EAES) [J]. Surg Endosc,2004,18(8): 1163-1185.
  • 8李国新,梁耀泽.腹腔镜结直肠癌手术应用及其评价[J].中国实用外科杂志,2010,30(3):186-190. 被引量:68
  • 9李国新,丁自海,张策,余江,黄祥成,钟世镇.腹腔镜下肠系膜下血管的临床解剖学[J].解剖学杂志,2006,29(5):624-626. 被引量:14
  • 10李国新,丁自海,张策,黄祥成,钟世镇.腹腔镜下左半结肠切除术相关筋膜平面的解剖观察[J].中国临床解剖学杂志,2006,24(3):298-301. 被引量:60

二级参考文献58

共引文献173

同被引文献36

  • 1Fausto Meriggi,Paola Bertocchi,Alberto Zaniboni.Management of potentially resectable colorectal cancer liver metastases[J].World Journal of Gastrointestinal Surgery,2013,5(5):138-145. 被引量:6
  • 2Jonker DJ, O' Callaghan CJ, Karapetis CS, et al. Cetuximab for the treatment of colorectal cancer [ J]. N Engl J Med, 2007,357 (20) :2040-2048.
  • 3美国国家综合癌症网络(NCCN,NationalComprehensiveCancerNetwork).结直肠癌临床实践指南(中文版)[S].2013.
  • 4Eichler HG, Kong SX, Gerth WC,et al. Use of cost-effective- ness analysis in health-care resource allocation decision- making: how are cost-effectiveness thresholds expected to emerge [J]. Valuein Health, 2004,7(5) :518-528.
  • 5National bureau of statistics of China. China statistical year book [ M ]. Beijing: China Statistics Press,2011.18.
  • 6Lawrence D, Maschio M, Leahy K J, et al. Economic analy- sis of bevacizumab, cetuximab, and panitumumab with flu- oropyrimidine-based chemotherapy in the first-line treatment of KRAS wild-type metastatic colorectal cancer (mCRC) [J]. J Med Eeon, 2013, 16(12) :1387-1398.
  • 7Ritvo P, Myers RE, Paszat L, et al. Gender differences in attitudes impeding colorectal Cancer screening [ J]. BMC Public Health, 2013,13(1) :500 -501.
  • 8程勇,王子卫,熊兵红,胡祥.腹腔镜结直肠癌根治术对血中CD44、ICAM-1和VCAM-1表达影响的研究[J].重庆医学,2009,38(5):516-518. 被引量:2
  • 9吴庆华,王明亮,郑民华.腹腔镜技术治疗结直肠癌的新观点及其争议[J].中国实用外科杂志,2009,29(4):355-358. 被引量:17
  • 10王道荣,陈兆雷,喻学桥,汤东,赵长勇,李洪波.经腹腔镜与开腹结直肠癌根治的疗效比较[J].南京医科大学学报(自然科学版),2009,29(5):729-731. 被引量:5

引证文献8

二级引证文献96

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部